Stay updated on Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-14T01:47:32.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the effectiveness or results related to the combination of chemotherapy drugs (carboplatin and nab-paclitaxel) with pembrolizumab for metastatic triple-negative breast cancer treatment.
    Difference
    0.1%
    Check dated 2024-06-06T15:58:42.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns medical and healthcare-related publications and documentation, specifically regarding the eligibility criteria for researchers looking for participants with metastatic triple negative breast cancer and the inclusion criteria for the clinical trial involving carboplatin, nab-paclitaxel, and pembrolizumab.
    Difference
    32%
    Check dated 2024-05-22T10:41:39.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention being highlighted. This change possibly relates to medical and healthcare-related publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T21:56:22.000Z thumbnail image

Stay in the know with updates to Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin Combo in Metastatic Triple-Negative Breast Cancer Clinical Trial page.